Session

Advanced liver diseases

TELEMEDICINE IN THE COVID-19 ERA FOR LIVER TRANSPLANT RECIPIENTS: AN ITALIAN LOCKDOWN AREA EXPERIENCE
TELEMEDICINE IN THE COVID-19 ERA FOR LIVER TRANSPLANT RECIPIENTS: AN ITALIAN LOCKDOWN AREA EXPERIENCE

Advanced liver diseases  et al.

AN END-TO-END ARTIFICIAL INTELLIGENCE MODEL ACCURATELY DIAGNOSING HEPATOCELLULAR CARCINOMA ON COMPUTED TOMOGRAPHY
AN END-TO-END ARTIFICIAL INTELLIGENCE MODEL ACCURATELY DIAGNOSING HEPATOCELLULAR CARCINOMA ON COMPUTED TOMOGRAPHY

Advanced liver diseases  et al.

TRANSPLANT-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING LOCOREGIONAL THERAPY - THE IMPACT OF SARCOPENIA AND SARCOPENIC OBESITY
TRANSPLANT-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING LOCOREGIONAL THERAPY - THE IMPACT OF SARCOPENIA AND SARCOPENIC OBESITY

Advanced liver diseases  et al.

CHECKPOINT INHIBITOR INDUCED HEPATITIS AND THE RELATION WITH LIVER METASTASIS AND OUTCOME IN METASTASIZED MELANOMA PATIENTS IN A REAL-LIFE COHORT: RESULTS FROM THE DUTCH MELANOMA TREATMENT REGISTRY
CHECKPOINT INHIBITOR INDUCED HEPATITIS AND THE RELATION WITH LIVER METASTASIS AND OUTCOME IN METASTASIZED MELANOMA PATIENTS IN A REAL-LIFE COHORT: RESULTS FROM THE DUTCH MELANOMA TREATMENT REGISTRY

Advanced liver diseases  et al.

PREVALENCE AND PREDICTORS OF ACUTE ON CHRONIC LIVER FAILURE IN CIRRHOTIC PATIENTS HOSPITALIZED FOR ACUTE DECOMPENSATION
PREVALENCE AND PREDICTORS OF ACUTE ON CHRONIC LIVER FAILURE IN CIRRHOTIC PATIENTS HOSPITALIZED FOR ACUTE DECOMPENSATION

Advanced liver diseases  et al.

Item 1 - 5 / 5
1